Cargando…

Plasma Endocan as a Predictor of Cardiovascular Event in Patients with End-Stage Renal Disease on Hemodialysis

Endocan, a potential biomarker of endothelial dysfunction, is associated with increased cardiovascular risk. We investigated the utility of plasma endocan for predicting cardiovascular risk in end-stage renal disease (ESRD) patients undergoing hemodialysis. Of the 452 patients in the K-cohort, 354 w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jin Sug, Ko, Gang Jee, Kim, Yang Gyun, Lee, So Young, Lee, Dong Young, Jeong, Kyung Hwan, Lee, Sang Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766985/ https://www.ncbi.nlm.nih.gov/pubmed/33352837 http://dx.doi.org/10.3390/jcm9124086

Ejemplares similares

Gait speed and handgrip strength as predictors of all-cause mortality and cardiovascular events in hemodialysis patients
por: Lee, Yu Ho, et al.
Publicado: (2020)

Plasma endocan level and prognosis of immunoglobulin A nephropathy
por: Lee, Yu Ho, et al.
Publicado: (2016)

Circulating Neprilysin Level Predicts the Risk of Cardiovascular Events in Hemodialysis Patients
por: Hwang, Hyeon Seok, et al.
Publicado: (2021)

Circulating PCSK9 Level and Risk of Cardiovascular Events and Death in Hemodialysis Patients
por: Hwang, Hyeon Seok, et al.
Publicado: (2020)

Circulating Vascular Adhesion Protein-1 Level Predicts the Risk of Cardiovascular Events and Mortality in Hemodialysis Patients
por: Kim, Dae Kyu, et al.
Publicado: (2021)

Endocan as a marker of microvascular inflammation in kidney transplant recipients
por: Lee, Yu Ho, et al.
Publicado: (2019)

Impact of sarcopenia on long-term mortality and cardiovascular events in patients undergoing hemodialysis
por: Kim, Jwa-Kyung, et al.
Publicado: (2019)

Effects of intermittent hemodialysis on plasmatic levels of endocan
por: Hureau, Maxence, et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response After Heterologous Immunizations With ChAdOx1/BNT162b2 in End-Stage Renal Disease Patients on Hemodialysis
por: Kim, Dae Kyu, et al.
Publicado: (2022)

Plasma Interleukin-6 Level Predicts the Risk of Arteriovenous Fistula Dysfunction in Patients Undergoing Maintenance Hemodialysis
por: Baek, Jihyun, et al.
Publicado: (2023)

The Relationship between Serum Endocan Levels and Depression in Alzheimer's Disease
por: Yoon, Kyung Hee, et al.
Publicado: (2016)

Plasma Endocan as a Biomarker of Thrombotic Events in COVID-19 Patients
por: Chenevier-Gobeaux, Camille, et al.
Publicado: (2022)

Are Endocan Plasma Levels Altered in Preeclampsia?
por: Lopes, Ana Cristina dos Santos, et al.
Publicado: (2021)

Clinical implications of circulating follistatin-like protein-1 in hemodialysis patients
por: Kim, Dae Kyu, et al.
Publicado: (2023)

Effect of blood pressure and glycemic control on the plasma cell-free DNA in hemodialysis patients
por: Jeong, Da Wun, et al.
Publicado: (2015)

Endocan: A Key Player of Cardiovascular Disease
por: Chen, Jinzhi, et al.
Publicado: (2022)

Interleukin-10 and Tumor Necrosis Factor-α Polymorphisms in Vascular Access Failure in Patients on Hemodialysis: Preliminary Data in Korea
por: Sung, Su Ah, et al.
Publicado: (2008)

Platelet activity with hemoglobin level in patients with hemodialysis: Prospective study
por: Kim, Jae Min, et al.
Publicado: (2020)

Serum osteoprotegerin is associated with vascular stiffness and the onset of new cardiovascular events in hemodialysis patients
por: Lee, Jung Eun, et al.
Publicado: (2013)

Endocan and Erectile Dysfunction
por: Balta, Sevket, et al.
Publicado: (2019)

Clinical validation of serum endocan (ESM-1) as a potential biomarker in patients with renal cell carcinoma
por: Kim, Kwang Hyun, et al.
Publicado: (2017)

Effects of online hemodiafiltration on anemia and nutritional status in chronic hemodialysis patients
por: Lee, Yu Ho, et al.
Publicado: (2020)

Comparison of Humoral Response between Third and Fourth Doses of COVID-19 Vaccine in Hemodialysis Patients
por: Joo, Yoosun, et al.
Publicado: (2023)

Effects of the route of erythropoietin administration on hemoglobin variability and cardiovascular events in hemodialysis patients
por: Kim, Do Hyoung, et al.
Publicado: (2021)

What applications for plasma endocan measurement in intensive care? A clarification
por: Dubar, Victoria, et al.
Publicado: (2023)

Hyperphosphatemia is associated with patency loss of arteriovenous fistula after 1 year of hemodialysis
por: Moon, Ju-Young, et al.
Publicado: (2015)

The Role of Endocan in Cardiometabolic Disorders
por: Klisic, Aleksandra, et al.
Publicado: (2023)

Urinary mRNA Signatures as Predictors of Renal Function Decline in Patients With Biopsy-Proven Diabetic Kidney Disease
por: Lee, Yu Ho, et al.
Publicado: (2021)

Serum endocan as a predictive biomarker of cardiovascular risk in obese pediatric patients
por: Morace, Carmela, et al.
Publicado: (2023)

Fatal anaphylaxis Due to Nafamostat Mesylate During Hemodialysis
por: Kim, Joo-Hee, et al.
Publicado: (2021)

Cardiothoracic Ratio as a Predictor of Cardiovascular Events in a Cohort of Hemodialysis Patients
por: Okute, Yujiro, et al.
Publicado: (2017)

Characteristics of Serum Endocan Levels in Infection
por: Seo, Kazunori, et al.
Publicado: (2015)

Endocan: A novel circulating proteoglycan
por: Kali, Arunava, et al.
Publicado: (2014)

Expressions of Endocan in Patients with Meningiomas and Gliomas
por: Atukeren, Pinar, et al.
Publicado: (2016)

Endocan and the respiratory system: a review
por: Kechagia, Maria, et al.
Publicado: (2016)

The Role of Endocan in Selected Kidney Diseases
por: Nalewajska, Magdalena, et al.
Publicado: (2020)

Serum Endocan Levels and Subclinical Atherosclerosis in Patients with Chronic Kidney and End-Stage Renal Diseases
por: El-Senosy, Fatma M., et al.
Publicado: (2022)

0730. Plasma endocan levels are associated with endothelial dysfunction during experimental human endotoxemia
por: van Eijk, LT, et al.
Publicado: (2014)

The refit model for end-stage liver disease-Na is not a better predictor of mortality than the refit model for end-stage liver disease in patients with cirrhosis and ascites
por: Kim, Jun Jae, et al.
Publicado: (2014)

The paradoxical effect of aldosterone on cardiovascular outcome in maintenance hemodialysis patients
por: Choi, Sun Ryoung, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_io0tm85dis8bprf5mfqd1fiscq